---
title: "mechanical circulatory support"
slug: "mechanical-circulatory-support"
date: "2023-02-12"
enableToc: false
tags:
- building
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[Treatment of acute advanced heart failure]]

# mechanical circulatory support

* Temporary: bridge to recovery, transplant, or durable MCS; periprocedural support

* Intra-aortic balloon pump (IABP): inflates in diastole & deflates in systole to â†“ impedance to LV ejection, â†“ myocardial O2 demand & â†‘ coronary perfusion; +0.5 L/min CO

* Axial flow pumps (eg, Impella): Archimedes screw principle in LV; +3.7â€“5.5 L/min

* Extracorporeal centrifugal pumps: TandemHeart (+5 L/min, percutaneous) & CentriMag (10 L/min, surgical)

* [[Extracorporeal membrane oxygenation]] (ECMO): 6 L/min (JACC HF 2018;6:503)

* Durable: surgically placed LVAD Â± RVAD as bridge to sufficient recovery (in 5â€“50% of niCMP; JACC 2017;69:1924), to transplant or as destination Rx (>50% â†“ 1-y mort. vs. med Rx; NEJM 2001;345:1435 & 2009;361:2241). Current preferred option is fully magnetically levitated centrifugal flow pump (HeartMate 3), â†“ stroke or re-op vs. axial flow models (NEJM 2019;380:1618).


## Explain by ChatGPT

in end-stage HF; NEJM 2009;361:2241), or as a mechanical circulatory support (MCS) device

# Mechanical circulatory support

* Temporary: bridge to recovery, transplant, or durable MCS; periprocedural support

* Intra-aortic balloon pump (IABP): inflates in diastole & deflates in systole to â†“ impedance to LV ejection, â†“ myocardial O2 demand & â†‘ coronary perfusion; +0.5 L/min CO

* Axial flow pumps (eg, Impella): Archimedes screw principle in LV; +3.7â€“5.5 L/min

* Extracorporeal centrifugal pumps: TandemHeart (+5 L/min, percutaneous) & CentriMag (10 L/min, surgical)

* [[Extracorporeal membrane oxygenation]] (ECMO): 6 L/min (JACC HF 2018;6:503)

* Durable: surgically placed LVAD Â± RVAD as bridge to sufficient recovery (in 5â€“50% of niCMP; JACC 2017;69:1924), to transplant or as destination Rx (in end-stage HF; NEJM 2009;361:2241), or as a mechanical circulatory support (MCS) device

## çª©çš„è‹±æ–‡ä¸å¤ªå¥½

åœ¨æ™šæœŸ HF ä¸­ï¼› NEJM 2009;361:2241)ï¼Œæˆ–ä½œç‚ºæ©Ÿæ¢°å¾ªç’°æ”¯æŒ (MCS) è¨­å‚™

# æ©Ÿæ¢°å¾ªç’°æ”¯æŒ

* è‡¨æ™‚ï¼šéæ¸¡åˆ°æ¢å¾©ã€ç§»æ¤æˆ–æŒä¹…çš„ MCSï¼›åœæ‰‹è¡“æœŸæ”¯æŒ

* ä¸»å‹•è„ˆå…§çƒå›Šæ³µ (IABP)ï¼šåœ¨èˆ’å¼µæœŸå……æ°£ï¼Œåœ¨æ”¶ç¸®æœŸæ”¾æ°£ï¼Œä»¥é™ä½ LV å°„è¡€é˜»æŠ—ã€â†“ å¿ƒè‚Œ O2 éœ€æ±‚å’Œ â†‘ å† ç‹€å‹•è„ˆçŒæ³¨ï¼› +0.5 å‡/åˆ†é˜ä¸€æ°§åŒ–ç¢³

* è»¸æµæ³µï¼ˆä¾‹å¦‚ Impellaï¼‰ï¼šLV ä¸­çš„é˜¿åŸºç±³å¾·èºæ—‹åŸç†ï¼› +3.7â€“5.5 å‡/åˆ†é˜

* é«”å¤–é›¢å¿ƒæ³µï¼šTandemHeartï¼ˆ+5 L/minï¼Œç¶“çš®ï¼‰å’Œ CentriMagï¼ˆ10 L/minï¼Œæ‰‹è¡“ï¼‰

* [[é«”å¤–è†œè‚ºæ°§åˆ]] (ECMO)ï¼š6 L/min (JACC HF 2018;6:503)

* è€ç”¨ï¼šæ‰‹è¡“æ”¾ç½® LVAD Â± RVAD ä½œç‚ºå……åˆ†æ¢å¾©çš„æ©‹æ¨‘ï¼ˆåœ¨ 5-50% çš„ niCMP ä¸­ï¼›JACC 2017ï¼›69:1924ï¼‰ï¼Œç”¨æ–¼ç§»æ¤æˆ–ä½œç‚ºç›®çš„åœ° Rxï¼ˆåœ¨çµ‚æœ«æœŸ HFï¼›NEJM 2009ï¼›361:2241ï¼‰ ï¼Œæˆ–ä½œç‚ºæ©Ÿæ¢°å¾ªç’°æ”¯æŒ (MCS) è¨­å‚™